• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Context Therapeutics Inc (NQ: CNTX )

    2.450 UNCHANGED
    Streaming Delayed Price Updated: 11:00 AM EDT, Aug 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 11,474
    Open 2.470
    Bid (Size) 2.430 (1)
    Ask (Size) 2.450 (2)
    Prev. Close 2.450
    Today's Range 2.440 - 2.490
    52wk Range 0.7700 - 2.750
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results
    From Context Therapeutics Inc.
    Via GlobeNewswire
    Context Therapeutics Appoints Chief Medical Officer and Vice President of Clinical Operations
    From Context Therapeutics Inc.
    Via GlobeNewswire

    Performance

    YTD
    +97.58%
    +97.58%
    1 Month
    +15.02%
    +15.02%
    3 Month
    +22.50%
    +22.50%
    6 Month
    +114.91%
    +114.91%
    1 Year
    +126.94%
    +126.94%

    More News

    Read More
    Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95
    From Context Therapeutics Inc.
    Via GlobeNewswire
    Hypergrowth Hits: 3 Stocks Clocking Triple-Digit Gains with No End in Sight
    Via InvestorPlace
    The 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit Gains
    Via InvestorPlace
    CNTX Stock Earnings: Context Therapeutics Beats EPS for Q1 2024
    Via InvestorPlace
    Context Therapeutics Reports First Quarter 2024 Operating and Financial Results
    From Context Therapeutics Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76
    From Context Therapeutics Inc.
    Via GlobeNewswire
    Context Therapeutics Announces $100 Million Private Placement
    From Context Therapeutics Inc.
    Via GlobeNewswire
    Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers
    From Context Therapeutics Inc.
    Via GlobeNewswire
    CNTX Stock Earnings: Context Therapeutics Misses EPS for Q4 2023
    Via InvestorPlace
    Context Therapeutics Reports Full Year 2023 Operating and Financial Results
    From Context Therapeutics Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Constellation Energy, Battalion Oil And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results
    From Context Therapeutics Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Context Therapeutics Announces Preclinical Data Demonstrating Differentiated and Active Profile of its Claudin 6-Targeted Bispecific Antibody CTIM-76
    From Context Therapeutics Inc.
    Via GlobeNewswire
    10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Why AERWINS Technologies Shares Are Trading Higher By Around 90%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.